Peter Jørgensen: Patient Engagement on Biosimilars

Peter Jørgensen, director of the Industrial Association for Generic and Biosimilar Medicines, Denmark, explains how Denmark has engaged with patients on biosimilars.
August 12, 2019



Transcript

What we have done in Denmark is, actually, we have taken the patients onboard. In the decision-making process, we have developed information for patients, which has been done by the authorities, not by companies, but by the authorities in cooperation with the patients. They have not been able to dictate the contents, but their concerns and their questions have been taken into consideration and have been answered.

If you look, for instance, at the website of the Danish Medicines Agency, you will see some very convincing “yes” answers or “no” answers to some of the most normal questions that patients might have about biosimilars.

But I think the main thing is to explain to people that, no, you’re not getting a new treatment. You’re not getting a new product. You’re simply getting another producer at a much lower price. It’s not a new treatment. It’s not really switching in the sense where we normally use that word. 

Language is of course important. It’s very, if you will, uphill to try to change people’s perception of language and what you interpret when you use special words. That is also true in this area.

x-button

Click here to view Biosimilars CME Activities

Click here to view Biosimilars PTCE Activities

Health economics experts. Managed care professionals. Key clinical specialists. This is where the worlds of clinical, regulatory, and economical outcomes for specialized pharmaceutical biotechnology meet: The Center for Biosimilars is your online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. We’ll discuss the current landscape for advanced health care management—reviewing emerging treatment paradigms, approaches, and considerations—all by authoritative industry voices.

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright © 2006-2019 Intellisphere, LLC. All Rights Reserved.